Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 December 2018 | Story Leonie Bolleurs | Photo Sonia Small
David Abbey
David Abbey is also serving on the UFS Council’s Finance, Audit, Risk and IT Governance Committee.

David Abbey, a senior banker and transactor in the Acquisition and Leveraged Finance Division at Rand Merchant Bank in Johannesburg, was appointed to the UFS Council.

An undergraduate student of Rhodes University, David is also a proud product of the UFS, having completed his Accounting honours degree at this university. For the past few years, he has also guest lectured on investment banking and financial instruments to Accounting honours students as part of the PwC Financial Instruments Programme.

Large-scale impact

Therefore, his appointment to the Council is particularly special to him.

“Being a member of the Council gives me the platform to have a more large-scale impact on the institution, academic community, the economy, and society. I’m thrilled to be serving alongside an astute body of incredible individuals from whom I will undoubtedly learn,” he says.

Realising his full potential

David is serving on the Council’s Finance, Audit, Risk and IT Governance Committee and his experience in, and knowledge of finance, technology, and audit skills will stand him in good stead. When he’s not developing and structuring innovative, multidisciplinary, and integrated financial solutions for his corporate clients, he loves to be active. He is a regular gym-goer and plays and watches all kinds of sport. Travel, the arts, and motoring are some of his other passions. 

On a personal level, there is still much he wants to achieve. “I want to continue to work hard, using my God-given talents to realise my full potential and to make a humble mark in society and in people’s lives.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept